"Bridged-Ring Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cyclic hydrocarbons that contain multiple rings which share one or more bridgehead connections.
Descriptor ID |
D001952
|
MeSH Number(s) |
D02.455.426.100 D04.075
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bridged-Ring Compounds".
Below are MeSH descriptors whose meaning is more specific than "Bridged-Ring Compounds".
This graph shows the total number of publications written about "Bridged-Ring Compounds" by people in this website by year, and whether "Bridged-Ring Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2003 | 1 | 1 | 2 |
2004 | 2 | 1 | 3 |
2005 | 1 | 4 | 5 |
2006 | 2 | 2 | 4 |
2007 | 0 | 3 | 3 |
2008 | 2 | 0 | 2 |
2009 | 0 | 2 | 2 |
2010 | 1 | 3 | 4 |
2011 | 2 | 2 | 4 |
2012 | 2 | 2 | 4 |
2013 | 1 | 6 | 7 |
2014 | 0 | 1 | 1 |
2015 | 1 | 5 | 6 |
2016 | 2 | 2 | 4 |
2017 | 3 | 4 | 7 |
2018 | 2 | 1 | 3 |
2019 | 0 | 2 | 2 |
2020 | 1 | 4 | 5 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bridged-Ring Compounds" by people in Profiles.
-
Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia. Haematologica. 2022 07 01; 107(7):1599-1607.
-
Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burden. Blood Adv. 2020 12 08; 4(23):5929-5935.
-
Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis. Blood Adv. 2020 11 24; 4(22):5825-5835.
-
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. JAMA Oncol. 2020 09 01; 6(9):1355-1362.
-
The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance. Gynecol Oncol. 2020 09; 158(3):653-658.
-
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial. JAMA Oncol. 2020 03 01; 6(3):367-374.
-
Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients. Medicine (Baltimore). 2020 Feb; 99(9):e19295.
-
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma. Clin Cancer Res. 2020 02 15; 26(4):892-901.
-
Outcomes in patients with metastatic bladder cancer in the USA: a retrospective electronic medical record study. Future Oncol. 2019 Apr; 15(12):1323-1334.
-
Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS). Support Care Cancer. 2019 Mar; 27(3):1021-1028.